|1.||Liu, Ying: 1 article (08/2015)|
|2.||Lai, Luhua: 1 article (08/2015)|
|3.||Meng, Hu: 1 article (08/2015)|
|4.||Hergenrother, Paul J: 1 article (01/2014)|
|5.||Fan, Timothy M: 1 article (01/2014)|
|6.||Im, Isak: 1 article (01/2014)|
|7.||Borst, Luke B: 1 article (01/2014)|
|8.||Botham, Rachel C: 1 article (01/2014)|
|9.||Dirikolu, Levent: 1 article (01/2014)|
|10.||Motabar, Omid: 1 article (01/2012)|
01/29/2014 - "These data suggest the potential of PAC-1/1541B combinations for the treatment of cancer and, more broadly, demonstrate that differentially acting enzyme activators can potently synergize to give a significantly heightened biological effect. "
01/01/2006 - "Inhibitors and activators of enzymes controlling epigenetic modifications are considered useful not only as tools for the elucidation of cellular and biological phenomena, but also as therapeutic agents, since disruption of the balance of epigenetic networks is known to cause some disease states such as cancer. "
06/01/2007 - "Using these same highly metastatic cells, primary tumors were grown in mice of separate groups fed 0, 0.1, 0.5, and 1% CLA (wt:wt) and evaluated for their levels and activities of matrix-modifying enzymes, enzyme inhibitors, and enzyme activators. "
|2.||Mitochondrial Diseases (Mitochondrial Disease)
08/18/2015 - "Strategies were then developed to predict potential allosteric sites and to discover enzyme activators based on our hypothesis that combined treatment with the projected activators and inhibitors could balance different AA network pathways, control inflammation, and reduce associated adverse effects. "